Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC

Clinical trial NCT05626569 · UNKNOWN

Trial details

NCT number: NCT05626569
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma Oligometastatic Disease

Start date: 2022-12-10
Primary completion: 2025-01-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.